XML 63 R7.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Cash Flows from Operating Activities    
Net loss $ (67,484) $ (37,940)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,697 1,409
Loss on disposal of property and equipment 122 1
Stock-based compensation 6,056 1,419
Preferred stock warrant liability revaluation 123 33
Accretion of discount on investments (800)  
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (2,394) (1,370)
Accounts payable 826 698
Accrued expenses 2,465 1,085
Other current liabilities 160  
Deferred rent 691 (35)
Net cash used in operating activities (58,538) (34,700)
Cash Flows from Investing Activities    
Purchase of property and equipment (3,447) (1,764)
Purchase of investments (99,646)  
Proceeds from maturities of investments 75,000 22,398
Change in deposits 189 24
Net cash provided by (used in) investing activities (27,904) 20,658
Cash Flows from Financing Activities    
Proceeds from issuance of convertible preferred stock, net   120,306
Proceeds from the issuance of common stock under the Employee Stock Purchase Plan 133  
Proceeds from exercise of stock options 303 46
Proceeds from initial public offering, net 133,633  
Principal payments on capital lease obligations (47) (48)
Payments of initial offering costs (2,848)  
Net cash provided by financing activities 131,174 120,304
Net change in cash, cash equivalents and restricted cash 44,732 106,262
Cash, cash equivalents and restricted cash, beginning of period 114,504 8,242
Cash, cash equivalents and restricted cash, end of period 159,236 114,504
Supplemental Disclosure of Cash Flow Information    
Cash paid for interest 6 9
Cash paid for income taxes 1 $ (1)
Supplemental Schedule of Non-Cash Investing and Financing Activities    
Conversion of redeemable convertible preferred stock to common stock 209,668  
Reclassification of redeemable convertible preferred stock warrant liability to additional paid-in capital 503  
Vesting of early exercised common stock options $ 15